MadeMed Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.3/10
Best for: compounded semaglutide at $239/month, billed quarterly
MadeMed scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on price, and it serves 43 states. Its compounded semaglutide costs $219 a month, paid up front, 10% above the $199 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
charged as a multi-month plan up front
Covered by the monthly price
Medication
Not stated
Clinician visits
Not stated
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
MadeMed, run by IDL Health LLC in Houston with clinical care from Xpedicare, LLC, sells compounded semaglutide and tirzepatide as injections or sublingual tablets, one flat price at every dose. There is no monthly plan: injectable semaglutide is $239 a month billed $717 every 3 months, or $199 a month on a 6-month plan. The tablets reach 40 states, the injections only 23.
Is MadeMed legit?
Yes. MadeMed is a real, operating US company, and we found no FDA warning letters issued to it. Its site shows LegitScript certification. We rate it 7.3/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a MadeMed promo or coupon code?
We know of no promo or coupon code for MadeMed. Its listed price is $219 a month. Coupon sites advertising "MadeMed discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how MadeMed compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to MadeMed
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
Luvo Health
Best for: moving between compounded and brand without changing seller
Editorial score · methodology
MadeMed at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $219/mo
- Availability
- 43 states
- FDA status
- No FDA warning letters found
How MadeMed scores
Six columns, each one computed from something MadeMed has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
4.3/10$219/month is 10% above the $199 median for compounded semaglutide across the sellers we compare. Every listed price requires paying for several months up front.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
7.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information. It lists the states it serves.
Accessibility10%
8.9/10Serves 43 of 50 states.
Support10%
5.0/10States too little about what the monthly cost covers to score the bundle. Held at the midpoint rather than assumed.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on MadeMed
Last checked October 2026- Checked the listed price across 4 dose or plan tiers
- Checked state coverage: 43 states
- Checked FDA warning letters for MadeMed
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with MadeMed involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1MadeMed shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask MadeMed which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- Lowest ongoing monthly price: semaglutide $219, tirzepatide $299. That leaves out membership fees, first-month rates and insurance copays.
- MadeMed serves 43 of 50 states, so check that yours is one of them.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting MadeMed
- Phone
- +1 (800) 582-1428
- MadeMed offers email support
Cancelling MadeMed
Taken from the terms MadeMed publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- 3- or 6-month plans billed up front for each term
- Refund policy
- Full refund minus a $39 visit fee if not prescribed; all dispensed sales final; no prorated refunds
- Early-termination fee
- None
Medications MadeMed lists
MadeMed lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Peptides MadeMed offers
MadeMed sells peptides beyond the GLP-1s. Tap one to read what the evidence says about it.
Pricing
Prices re-verified
$239/mo on the quarterly plan; a 6-month plan cuts it to $199/mo, the product page's from-price. Includes L-Carnitine. One vial ships every 2 months. Sold in 23 states.
$399/mo quarterly; 6-month $369/mo. One vial ships every 2 months. Sold in 23 states.
$219/mo quarterly; 6-month $179/mo. Includes B6. 60 tablets ship every 2 months. Sold in 40 states.
$299/mo quarterly; 6-month $279/mo. 60 tablets ship every 2 months. Sold in 40 states.
Check the price yourself before you pay
Every figure here comes from MadeMed's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Tirzepatide costs $299 a month, close to the $269 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- Serves 43 states
- We found no FDA warning letters issued to MadeMed
Against it
- Semaglutide costs $219 a month, 10% above the $199 median for compounded semaglutide across the sellers we compare
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What MadeMed charges
MadeMed charges $219/month.
- Compounded semaglutide (injection): $239/month
- Compounded tirzepatide (injection): $399/month
- Compounded semaglutide (sublingual): $219/month
- Compounded tirzepatide (sublingual): $299/month
For compounded semaglutide, the median across the sellers we compare is $199/month, so MadeMed's $219 lands mid-market. Price is unlikely to be the deciding factor. Some of MadeMed's plans are paid several months up front, so read the terms you agree to at checkout before you choose a longer one.
Belle Health dispenses semaglutide and tirzepatide from $199/month, which makes it the fair comparison to run before you commit here.
What MadeMed dispenses
MadeMed prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. The medication is compounded rather than dispensed as an approved pen. Compounding serves real clinical needs and is entirely lawful; what it is not is reviewed, and the cost difference reflects that. The molecule can be the one in Ozempic and Wegovy; what differs is the formulation, the concentration and the dose ladder.
A needle-free oral option is genuinely uncommon and is the reason some readers will look at MadeMed at all. Set expectations on the evidence, though: the published weight-loss trials for these molecules used injections. Oral and sublingual delivery of peptides is far less studied, so treat it as a route that solves the needle problem rather than as a proven equal to the shot. No human absorption study of sublingual semaglutide drops has been published.
Safety and disclosure
MadeMed tells you its price before you start the medical questionnaire and the 43 states it serves. We found no FDA warning letters issued to MadeMed. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If MadeMed will not tell you, treat that as a warning sign. A 503A pharmacy answers to a state board and a 503B facility to the FDA; which one fills it changes what you can check. How we weigh oversight, disclosure and price is set out in our scoring methodology.
MadeMed also sells NAD+, and a 2026 systematic review found no outcomes trials of injected NAD+ for anti-aging or wellness.
Who should look elsewhere
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether MadeMed bills your plan before you start.
It fits if
- injections are the thing keeping you from starting
Our read
MadeMed lands mid-market on price without a standout advantage or an obvious problem. It comes down to whether its particular package fits you.
The Bottom Line
MadeMed scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on price, and it serves 43 states. Its compounded semaglutide costs $219 a month, paid up front, 10% above the $199 median among the sellers we compare.
Before you pay MadeMed
Starting at $219 a month. Check today's price, then start the intake.
Where MadeMed is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
- If you want a human checking in, not just a prescription, consider Eden.
If none of these fits, our guide to alternatives to MadeMed sets more sellers in the same category beside MadeMed on price, states and what the price includes.
Frequently Asked Questions
How to check MadeMed yourself
- We Read FDA's Register of Compounding Facilities. 43 of 100 Have Never Been Inspected.
- Buying Tirzepatide as a Research Chemical: What "Research Use Only" Really Means
- FDA Warning Letters to Peptide Sellers: What FDA Has Cited, 2023 to 2026
Every seller that ships to your state, side by side: Colorado, Kansas, Michigan, Minnesota, Mississippi, New Mexico, Pennsylvania, South Dakota and every other state.
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this MadeMed review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See MadeMed's current pricing
Plans start at $219 a month. Whether you qualify is a clinician's decision, made after your intake.